| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
72,278,000 |
| Market
Cap: |
5.91(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$51.07 - $92.87 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 213 |
| Guru Rank Value : 5.7 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Lantheus Holdings is engaged in the development, manufacture and commercialization of diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart disease, cancer and other diseases. Co.'s commercial products include DEFINITY, which is a microbubble ultrasound enhancing agent used in ultrasound exams of the heart, also known as echocardiography exams; and TechneLite, which is a Technetium (Tc-99m) generator that provides the nuclear material used by radiopharmacies to radiolabel Cardiolite, Neurolite and other Tc-99m-based radiopharmaceuticals used in nuclear medicine procedures.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
180,261 |
191,284 |
236,664 |
669,864 |
| Total Sell Value |
$11,892,313 |
$12,738,459 |
$15,814,303 |
$49,198,503 |
| Total People Sold |
7 |
7 |
9 |
11 |
| Total Sell Transactions |
11 |
15 |
26 |
77 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Heino Mary Anne |
President & CEO |
• • – |
2018-08-31 |
4 |
D |
$16.10 |
$156,154 |
D/D |
(9,699) |
640,346 |
|
- |
|
| Mchugh Julie |
Director |
– • – |
2018-06-25 |
4 |
AS |
$14.72 |
$67,123 |
D/D |
(4,560) |
14,752 |
|
- |
|
| Bolla John J. |
See Remarks |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,620 |
22,620 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-05-01 |
4 |
AS |
$18.00 |
$81,370 |
D/D |
(4,510) |
90,806 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-04-30 |
4 |
AS |
$18.00 |
$10,800 |
D/D |
(600) |
95,316 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-04-27 |
4 |
AS |
$18.00 |
$147,657 |
D/D |
(8,201) |
95,916 |
|
- |
|
| Crowley John W. |
CFO |
• – – |
2018-04-26 |
4 |
D |
$17.90 |
$81,714 |
D/D |
(4,565) |
161,825 |
|
- |
|
| Duffy Michael P |
See Remarks |
• – – |
2018-04-26 |
4 |
D |
$17.90 |
$119,590 |
D/D |
(6,681) |
157,478 |
|
- |
|
| Heino Mary Anne |
President & CEO |
• • – |
2018-04-26 |
4 |
D |
$17.90 |
$527,137 |
D/D |
(29,449) |
650,045 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-04-26 |
4 |
AS |
$18.00 |
$75,492 |
D/D |
(4,194) |
104,117 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-04-26 |
4 |
D |
$17.90 |
$59,321 |
D/D |
(3,314) |
108,311 |
|
- |
|
| Duffy Michael P |
See Remarks |
• – – |
2018-04-03 |
4 |
AS |
$15.30 |
$417,897 |
D/D |
(27,313) |
164,159 |
|
- |
|
| Duffy Michael P |
See Remarks |
• – – |
2018-04-03 |
4 |
OE |
$5.62 |
$153,499 |
D/D |
27,313 |
191,472 |
|
- |
|
| Duffy Michael P |
See Remarks |
• – – |
2018-03-14 |
4 |
AS |
$16.60 |
$190,775 |
D/D |
(11,492) |
164,159 |
|
- |
|
| Robertson A Frederick |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
41,641 |
|
- |
|
| Clemmer James C |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
48,634 |
|
- |
|
| Heino Mary Anne |
President & CEO |
• • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
120,253 |
679,494 |
|
- |
|
| Crowley John W. |
CFO |
• – – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,193 |
166,390 |
|
- |
|
| Thrall James H |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
7,911 |
|
- |
|
| Mchugh Julie |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
19,312 |
|
- |
|
| Pruden Gary J |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
7,911 |
|
- |
|
| Orlandi Cesare |
Chief Medical Officer |
• – – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,629 |
111,625 |
|
- |
|
| Leno Sam R |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
48,177 |
|
- |
|
| Duffy Michael P |
See Remarks |
• – – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,967 |
175,651 |
|
- |
|
| Pucel Kenneth |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,911 |
7,911 |
|
- |
|
556 Records found
|
|
Page 17 of 23 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.31 (1.63%) 
